AI-generated summary
The authors report an open prospective study of 279 patients with various skin conditions treated with 308 nm monochromatic excimer light, about 12 weekly sessions on average. They report complete remission in over 50% of patients with plaque psoriasis and palmoplantar dermatoses, complete remission in all mycosis fungoides patients, and excellent repigmentation in one third of vitiligo patients. Findings in several other conditions were described as preliminary.
- Participants
- 279
- Who or what was studied
- Patients with plaque psoriasis, palmoplantar psoriasis and pustulosis, vitiligo, mycosis fungoides, alopecia areata, prurigo nodularis, localized scleroderma, genital lichen sclerosus, and granuloma annulare
- Wavelengths
- 308 nm
- Limits stated in the abstract
- The study was open and prospective, and the abstract reports small subgroups for several conditions, with follow-up of only 4 months for some.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 308 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Ultraviolet, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.